• Probe malfunction during TEE is an underrecognized problem. • MR severity assessment: host (e.g., BP), technical (e.g., gain), probe malfunction. • Clues for malfunction 1: disparity between TTE and TEE; CW and color Doppler. • Clues for malfunction 2: unexplained poor image quality; need for high gain. • Transducer temperature can affect image quality.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581639 | PMC |
| http://dx.doi.org/10.1016/j.case.2020.06.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Construction of a mitochondrial-targeting near-infrared fluorescent probe for detection of viscosity changes in type 2 diabetes mellitus and nonalcoholic steatohepatitis.
Talanta
December 2024
State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, 730000, China. Electronic address:
The intracellular viscosity plays a pivotal role as a physicochemical factor and an important indicator of organelles performance. Abnormal changes in subcellular viscosity are often associated with cellular malfunction and various diseases. Nonalcoholic steatohepatitis (NASH) is the most common liver disease related with type 2 diabetes mellitus (T2DM), and both are linked to aberrant mitochondrial viscosity.
View Article and Find Full Text PDFIntracranial multimodal monitoring in neurocritical care (Neurocore-iMMM): an open, decentralized consensus.
Crit Care
December 2024
Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Background: Intracranial multimodal monitoring (iMMM) is increasingly used in neurocritical care, but a lack of standardization hinders its evidence-based development. Here, we devised core outcome sets (COS) and reporting guidelines to harmonize iMMM practices and research.
Methods: An open, decentralized, three-round Delphi consensus study involved experts between December 2023 and June 2024.
Current evidence on artificial intelligence in regional anesthesia.
World J Clin Cases
November 2024
Department of Anaesthesiology, Tata Main Hospital, Jamshedpur 831001, India.
Article Synopsis
- Recent advancements in regional anesthesia (RA) owe much to ultrasound technology, but human factors like fatigue and misidentification of anatomy can affect performance.
- Integrating artificial intelligence (AI) and machine learning can enhance RA practices by improving anatomical recognition and providing real-time guidance during procedures.
- While the future of AI in RA looks promising, challenges such as device malfunctions, data privacy issues, regulatory obstacles, and cost remain significant hurdles to widespread implementation.
Repurposing large-format microarrays for scalable spatial transcriptomics.
Nat Methods
January 2025
Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL, USA.
Spatiomolecular analyses are key to study tissue functions and malfunctions. However, we lack profiling tools for spatial transcriptomics that are easy to adopt, low cost and scalable in terms of sample size and number. Here, we describe a method, Array-seq, to repurpose classical oligonucleotide microarrays for spatial transcriptomics profiling.
View Article and Find Full Text PDFAIE multifunctional probe empowering colorimetric-fluorescence dual-mode biosensor for early diabetic screening.
Biosens Bioelectron
February 2025
College of Material, Chemistry and Chemical Engineering, Key Laboratory of Organosilicon Chemistry and Material Technology, Ministry of Education, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, China. Electronic address:
Article Synopsis
- Diabetes mellitus (DM) is a chronic condition marked by high blood glucose levels, but traditional biomarkers often fail to detect early stages due to their variability.
- A novel dual-mode biosensor using α-glucosidase and modified copper nanoclusters has been developed for improved early diabetes screening, minimizing influences of blood glucose fluctuations.
- This biosensor significantly increases detection accuracy, reducing false positives by 50% and false negatives by 25%, making it a reliable tool for clinical evaluations of abnormal glucose levels.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!